Current landscape of palliative radiotherapy for non-small-cell lung cancer

Transl Lung Cancer Res. 2019 Sep;8(Suppl 2):S192-S201. doi: 10.21037/tlcr.2019.08.10.


Radiotherapy (RT) is a cornerstone in the management of advanced stage III and stage IV non-small-cell lung cancer (NSCLC) patients. Despite international guidelines, clinical practice remains heterogeneous. Additionally, the advent of stereotactic ablative RT (SABR) and new systemic treatments such as immunotherapy have shaken up dogmas in the approach of these patients. This review will focus on palliative thoracic RT for NSCLC but will also discuss the role of stereotactic radiotherapy, endobronchial brachytherapy (EBB), the interest of concomitant treatments (chemotherapy and immunotherapy), and the role of RT in lung cancer emergencies with palliative intent.

Keywords: Lung cancer; palliative intent; radiotherapy.

Publication types

  • Review